UK cost agency rebuffs Sanofi cholesterol drug but backs Amgen's

LONDON (Reuters) - Britain's cost watchdog has recommended that patients with high cholesterol should not get Sanofi and Regeneron's new cholesterol-lowering injection Praluent, although Amgen's similar drug Repatha will be available.

http://ift.tt/xePdMM

from Reuters: Health News
via animenewspro